metaPreg - Verapamil (versus unexposed) during pregnancy

Verapamil (versus unexposed)

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	2.51 [1.01, 6.28]	-	1 study	39	56	not evaluable	ROB	4.46 [1.08; .]
3 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	4.01 [1.98, 8.11]	-	1 study	59	55	not evaluable	ROB	7.48 [3.37; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
3 non statistically significant endpoints reported in only one study